Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
60–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients 60-75 years of age;
B-cell follicular NHL;
no previous treatment;
active disease, with rapid progression.
You may not be if
other cancer within 3 years of study, except carcinoma in situ of the cervix, basal or squamous cell skin cancer, localized prostate cancer, or ductal carcinoma in situ of the breast treated with lumpectomy;
long-term use (\>1 month) of systemic corticosteroids;
central nervous system involvement;
history of significant cardiovascular disease;
positive test result for HIV, or hepatitis B or C.
Clareo Health | A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
